Search for: "USA v. Doe" Results 1801 - 1820 of 4,127
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2015, 8:48 am by Cindy Cohn and Kurt Opsahl
As we argued to the Ninth Circuit after USA FREEDOM passed, the law still: ·      Creates a prior restraint on our clients that doesn’t follow the procedural protections created by the seminal Supreme Court case Freedman v. [read post]
18 Aug 2015, 4:47 am by Amy Howe
Guarneri “should guide the Court’s decision in” this Term’s Friedrichs v. [read post]
13 Aug 2015, 10:56 am
  A change made through the CBE process does not require preapproval by the FDA. [read post]
6 Aug 2015, 7:35 am by John F. Fullerton III
Energy (USA), LLC, 720 F.3d 620 (5th Cir. 2013), that a Dodd-Frank whistleblower must report wrongdoing to the Commission to be protected by that statute; a decision from the Second Circuit on the issue is pending in Berman v. [read post]
6 Aug 2015, 7:35 am by John Fullerton III
Energy (USA), LLC, 720 F.3d 620 (5th Cir. 2013), that a Dodd-Frank whistleblower must report wrongdoing to the Commission to be protected by that statute; a decision from the Second Circuit on the issue is pending in Berman v. [read post]
2 Aug 2015, 4:01 pm
Does she have any legal ground to do so, wonders Eleonora? [read post]
27 Jul 2015, 6:07 pm by LTA-Editor
By Miriam Swedlow Despite overruling the Federal Circuit’s prior practice of reviewing all aspects of patent claim construction de novo, the Supreme Court’s ruling in Teva Pharmaceuticals USA, Inc. v. [read post]